Certara Inc
CERT8.890USD
-0.020-0.22%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.42BMarket Cap
130.97P/E TTM
More Details of Certara Inc Company
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Certara Inc Info
Ticker SymbolCERT
Company nameCertara Inc
IPO dateDec 11, 2020
CEOFeehery (William F)
Number of employees1487
Security typeOrdinary Share
Fiscal year-endDec 11
Address4 Radnor Corporate Center, Suite 350
CityRADNOR
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19087
Phone14152378272
Websitehttps://www.certara.com/
Ticker SymbolCERT
IPO dateDec 11, 2020
CEOFeehery (William F)
Company Executives of Certara Inc
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
89.01K
+46.64%
Mr. Stephen M. Mclean
Mr. Stephen M. Mclean
Independent Director
Independent Director
42.00K
--
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
36.09K
+49.37%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
34.95K
+51.81%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
29.91K
+66.31%
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
5.18K
--
Mr. Adrian Mckemey, Ph.D.
Mr. Adrian Mckemey, Ph.D.
President - Certara Drug Development Solutions
President - Certara Drug Development Solutions
--
--
Dr. William F. (Bill) Feehery, Ph.D.
Dr. William F. (Bill) Feehery, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Matthew Walsh
Mr. Matthew Walsh
Independent Director
Independent Director
--
--
Ms. Cynthia L. Collins
Ms. Cynthia L. Collins
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
89.01K
+46.64%
Mr. Stephen M. Mclean
Mr. Stephen M. Mclean
Independent Director
Independent Director
42.00K
--
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
36.09K
+49.37%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
34.95K
+51.81%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
29.91K
+66.31%
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
5.18K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Americas
73.00M
69.80%
EMEA
23.36M
22.34%
Asia Pac
8.21M
7.85%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Arsenal Capital Management LP
22.82%
Wasatch Global Investors Inc
10.92%
BlackRock Institutional Trust Company, N.A.
8.09%
The Vanguard Group, Inc.
7.77%
Dimensional Fund Advisors, L.P.
5.24%
Other
45.15%
Shareholders
Shareholders
Proportion
Arsenal Capital Management LP
22.82%
Wasatch Global Investors Inc
10.92%
BlackRock Institutional Trust Company, N.A.
8.09%
The Vanguard Group, Inc.
7.77%
Dimensional Fund Advisors, L.P.
5.24%
Other
45.15%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
40.64%
Investment Advisor
33.22%
Private Equity
22.82%
Hedge Fund
9.63%
Pension Fund
4.93%
Bank and Trust
3.26%
Individual Investor
2.64%
Research Firm
1.28%
Venture Capital
0.40%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
558
185.12M
131.81%
+1.00M
2025Q3
573
184.07M
131.10%
+12.68M
2025Q2
560
171.32M
126.85%
+5.75M
2025Q1
564
165.12M
122.63%
-32.91M
2024Q4
543
158.45M
114.11%
+1.19M
2024Q3
537
155.91M
127.98%
-4.99M
2024Q2
523
160.73M
126.95%
+18.44K
2024Q1
516
160.66M
125.87%
-40.98M
2023Q4
507
159.05M
107.80%
-1.16M
2023Q3
508
160.16M
107.64%
+805.68K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Arsenal Capital Management LP
36.35M
22.63%
--
--
Apr 14, 2025
Wasatch Global Investors Inc
13.53M
8.43%
+4.24M
+45.69%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
12.30M
7.66%
+31.61K
+0.26%
Jun 30, 2025
The Vanguard Group, Inc.
12.41M
7.72%
-11.46K
-0.09%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
7.85M
4.89%
-70.89K
-0.89%
Jun 30, 2025
Deerfield Management Company, L.P.
3.93M
2.44%
+1.90M
+94.11%
Jun 30, 2025
ArrowMark Colorado Holdings, LLC
7.89M
4.91%
+387.77K
+5.17%
Jun 30, 2025
Geneva Capital Management LLC
6.11M
3.81%
+443.21K
+7.81%
Jun 30, 2025
Teacher Retirement System of Texas
5.67M
3.53%
+1.15M
+25.29%
Jun 30, 2025
Columbia Threadneedle Investments (UK)
4.91M
3.06%
+906.55K
+22.63%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
0.86%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.39%
First Trust Active Factor Small Cap ETF
0.22%
iShares U.S. Healthcare Providers ETF
0.22%
First Trust Small Cap Growth AlphaDEX Fund
0.22%
State Street SPDR S&P 600 Small Cap Value ETF
0.2%
Harbor Human Capital Factor US Small Cap ETF
0.19%
iShares S&P Small-Cap 600 Value ETF
0.15%
State Street SPDR S&P SmallCap 600 ESG ETF
0.14%
First Trust Small Cap Core Alphadex Fund
0.12%
View more
Invesco S&P SmallCap Health Care ETF
Proportion0.86%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.39%
First Trust Active Factor Small Cap ETF
Proportion0.22%
iShares U.S. Healthcare Providers ETF
Proportion0.22%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.22%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.2%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.19%
iShares S&P Small-Cap 600 Value ETF
Proportion0.15%
State Street SPDR S&P SmallCap 600 ESG ETF
Proportion0.14%
First Trust Small Cap Core Alphadex Fund
Proportion0.12%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Certara Inc?
The top five shareholders of Certara Inc are:
Arsenal Capital Management LP holds 36.35M shares, accounting for 22.63% of the total shares.
Wasatch Global Investors Inc holds 13.53M shares, accounting for 8.43% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.30M shares, accounting for 7.66% of the total shares.
The Vanguard Group, Inc. holds 12.41M shares, accounting for 7.72% of the total shares.
Dimensional Fund Advisors, L.P. holds 7.85M shares, accounting for 4.89% of the total shares.
Arsenal Capital Management LP holds 36.35M shares, accounting for 22.63% of the total shares.
Wasatch Global Investors Inc holds 13.53M shares, accounting for 8.43% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.30M shares, accounting for 7.66% of the total shares.
The Vanguard Group, Inc. holds 12.41M shares, accounting for 7.72% of the total shares.
Dimensional Fund Advisors, L.P. holds 7.85M shares, accounting for 4.89% of the total shares.
What are the top three shareholder types of Certara Inc?
The top three shareholder types of Certara Inc are:
Arsenal Capital Management LP
Wasatch Global Investors Inc
BlackRock Institutional Trust Company, N.A.
Arsenal Capital Management LP
Wasatch Global Investors Inc
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Certara Inc (CERT)?
As of 2025Q4, 558 institutions hold shares of Certara Inc, with a combined market value of approximately 185.12M, accounting for 131.81% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.72%.
What is the biggest source of revenue for Certara Inc?
In FY2025Q2, the -- business generated the highest revenue for Certara Inc, amounting to -- and accounting for --% of total revenue.
